Robuta

Sponsor of the Day: Jerkmate
https://www.regmednet.com/cell-therapy-weekly-biotech-emerges-from-stealth-with-parkinsons-disease-program/ Cell Therapy Weekly: Biotech Emerges from Stealth - RegMedNet Oryon Cell Therapies, specializing in autologous neuron replacement therapies for neurodegenerative disorders, has emerged from stealth. cell therapy weeklybiotechemergesstealthregmednet https://www.regmednet.com/cell-therapy-weekly-orphan-drug-designation-for-brain-cancer-car-t-cell-therapy/ Cell Therapy Weekly: Orphan Drug Designation for CAR-T Therapy - RegMedNet Jul 11, 2025 - Mustang Bio's CAR T-cell therapy MB-101 for astrocytoma and glioblastoma has received Orphan Drug Designation. cell therapy weeklyorphan drugdesignationcarregmednet https://www.regmednet.com/cell-therapy-weekly-fujifilm-irvine-scientific-completes-construction-of-cell-culture-media-manufacturing-facility-in-the-netherlands/ Cell therapy weekly: Fujifilm Irvine Scientific completes construction of cell culture media... Oct 27, 2021 - This week Fujifilm Irvine Scientific announces the completion of its new cell culture media manufacturing facility in the Netherlands, and much more. cell therapy weeklycompletes constructionculture mediafujifilmirvine https://www.regmednet.com/cell-therapy-weekly-phase-iii-results-for-brainstorm-cell-therapeutics-als-therapy-lead-to-rejection-by-fda-committee/ Cell therapy weekly: FDA rejects BrainStorm Cell Therapeutics ALS cell therapy, NurOwn Sep 29, 2023 - The amyotrophic lateral sclerosis treatment was deemed to have insignificant therapeutic benefit leading to an FDA rejection. cell therapy weeklyfdarejectsbrainstormtherapeutics